![David Silberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 117 700 $ al 30/06/2026
David Silberman currently works at Nasus Pharma Ltd., as Director from 2025 and Compugen Ltd., as Chief Financial Officer from 2024.
Mr. Silberman also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Manager-Global Internal Audit from 2018 to 2021 and Oramed Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer from 2021 to 2022.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
COMPUGEN LTD. 0,06 % | 29/07/2026 | 55.000 ( 0,06 % ) | 117 700 $ | 30/06/2026 |
NASUS PHARMA LTD. -.--% | 25/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| COMPUGEN LTD. | Director Financiero/CFO | 15/08/2024 |
| NASUS PHARMA LTD. | Director/Miembro de la Junta | 11/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director Financiero/CFO | 09/01/2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Comptroller/Controller/Auditor | 01/05/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Oramed Pharmaceuticals, Inc.
 Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Nasus Pharma Ltd.
 Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
